EP1996937A4 - Materiels génétiques et utilisations correspondantes - Google Patents
Materiels génétiques et utilisations correspondantesInfo
- Publication number
- EP1996937A4 EP1996937A4 EP07752549A EP07752549A EP1996937A4 EP 1996937 A4 EP1996937 A4 EP 1996937A4 EP 07752549 A EP07752549 A EP 07752549A EP 07752549 A EP07752549 A EP 07752549A EP 1996937 A4 EP1996937 A4 EP 1996937A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- genetic packages
- packages
- genetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74341006P | 2006-03-06 | 2006-03-06 | |
US74362206P | 2006-03-21 | 2006-03-21 | |
US11/528,950 US20070212703A1 (en) | 2005-09-27 | 2006-09-27 | Proteinaceous pharmaceuticals and uses thereof |
US11/528,927 US20070191272A1 (en) | 2005-09-27 | 2006-09-27 | Proteinaceous pharmaceuticals and uses thereof |
PCT/US2007/005857 WO2007103455A2 (fr) | 2006-03-06 | 2007-03-06 | Materiels génétiques et utilisations correspondantes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1996937A2 EP1996937A2 (fr) | 2008-12-03 |
EP1996937A4 true EP1996937A4 (fr) | 2009-04-08 |
Family
ID=38475542
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07752549A Withdrawn EP1996937A4 (fr) | 2006-03-06 | 2007-03-06 | Materiels génétiques et utilisations correspondantes |
EP07752636.6A Active EP1996220B2 (fr) | 2005-09-27 | 2007-03-06 | Polymères recombinés non structurés et utilisations correspondantes |
EP20140189047 Ceased EP2863222A1 (fr) | 2006-03-06 | 2007-03-06 | Polymères recombinants non structurés et leurs utilisations |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07752636.6A Active EP1996220B2 (fr) | 2005-09-27 | 2007-03-06 | Polymères recombinés non structurés et utilisations correspondantes |
EP20140189047 Ceased EP2863222A1 (fr) | 2006-03-06 | 2007-03-06 | Polymères recombinants non structurés et leurs utilisations |
Country Status (6)
Country | Link |
---|---|
EP (3) | EP1996937A4 (fr) |
AU (2) | AU2007223855B2 (fr) |
CA (1) | CA2644712C (fr) |
DK (1) | DK2402754T4 (fr) |
SI (1) | SI2402754T2 (fr) |
WO (2) | WO2007103455A2 (fr) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1583562T1 (sl) | 2003-01-06 | 2011-10-28 | Angiochem Inc | AngioPep-1, sorodne spojine in njihove uporabe |
US7846445B2 (en) | 2005-09-27 | 2010-12-07 | Amunix Operating, Inc. | Methods for production of unstructured recombinant polymers and uses thereof |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
US8334257B2 (en) | 2005-12-20 | 2012-12-18 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
SI2402754T2 (sl) | 2006-03-06 | 2023-09-29 | Amunix Operating Inc. | Nestrukturirani rekombinantni polimeri in njihove uporabe |
US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
CN101970678B (zh) | 2007-06-21 | 2014-08-20 | 慕尼黑科技大学 | 具有增加的体内和/或体外稳定性的生物学活性蛋白 |
CA2695374A1 (fr) * | 2007-08-15 | 2009-02-19 | Amunix, Inc. | Compositions et procedes d'amelioration de la production de polypeptides recombines |
EP3412300A1 (fr) | 2008-06-27 | 2018-12-12 | Duke University | Agents thérapeutiques comprenant des peptides de type élastine |
JP2012505637A (ja) | 2008-10-15 | 2012-03-08 | アンジオケム,インコーポレーテッド | Glp−1アゴニストのコンジュゲート及びその使用 |
JP5759379B2 (ja) | 2008-12-05 | 2015-08-05 | アンジオケム インコーポレーテッド | ニューロテンシンまたはニューロテンシンアナログおよびその使用 |
AU2015218510B2 (en) * | 2009-02-03 | 2016-11-10 | Amunix Pharmaceuticals, Inc. | Extended recombinant polypeptides and compositions comprising same |
US8716448B2 (en) * | 2009-02-03 | 2014-05-06 | Amunix Operating Inc. | Coagulation factor VII compositions and methods of making and using same |
US8703717B2 (en) | 2009-02-03 | 2014-04-22 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
US8680050B2 (en) | 2009-02-03 | 2014-03-25 | Amunix Operating Inc. | Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same |
CN102348715B (zh) | 2009-02-03 | 2017-12-08 | 阿穆尼克斯运营公司 | 延伸重组多肽和包含该延伸重组多肽的组合物 |
AU2014206217B2 (en) * | 2009-02-03 | 2015-09-17 | Amunix Pharmaceuticals, Inc. | Extended recombinant polypeptides and compositions comprising same |
WO2010121379A1 (fr) | 2009-04-20 | 2010-10-28 | Angiochem Inc | Traitement d'un cancer de l'ovaire à l'aide d'un agent anticancéreux conjugué à un analogue d'angiopep-2 |
US9849188B2 (en) | 2009-06-08 | 2017-12-26 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
KR101813727B1 (ko) * | 2009-06-08 | 2018-01-02 | 아뮤닉스 오퍼레이팅 인코포레이티드 | 성장 호르몬 폴리펩타이드 및 이를 제조하고 사용하는 방법 |
PT2440228T (pt) | 2009-06-08 | 2018-12-24 | Amunix Operating Inc | Polipéptidos de regulação da glicose e métodos de preparação e utilização dos mesmos |
EP2440241B1 (fr) * | 2009-06-08 | 2017-08-09 | Amunix Operating Inc. | Polypeptides d'hormone de croissance et leurs procédés de production et d'utilisation |
AU2010268726A1 (en) * | 2009-07-02 | 2012-01-19 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
EP2502939B1 (fr) * | 2009-11-19 | 2016-01-27 | Zhejiang University | Protéine non naturelle de type collagène et son utilisation |
WO2011069164A2 (fr) | 2009-12-06 | 2011-06-09 | Biogen Idec Ma Inc. | Polypeptides chimériques et hybrides de facteur viii-fc, et procédés d'utilisation de ceux-ci |
WO2011123830A2 (fr) * | 2010-04-02 | 2011-10-06 | Amunix Operating Inc. | Compositions d'alpha 1-antitrypsine, leurs procédés de préparation et d'utilisation |
WO2011123813A2 (fr) * | 2010-04-02 | 2011-10-06 | Amunix Operating Inc. | Protéines de fusion liantes, conjugués protéines de fusion liantes-médicaments, conjugués xten-médicaments et procédés pour les préparer et les utiliser |
AR081361A1 (es) | 2010-04-30 | 2012-08-29 | Molecular Partners Ag | Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a |
CN102883734B (zh) | 2010-05-21 | 2018-01-02 | Xl-蛋白有限责任公司 | 生物合成的脯氨酸/丙氨酸无规卷曲多肽及其用途 |
WO2011157819A2 (fr) | 2010-06-18 | 2011-12-22 | Xiberscience Gmbh | Peptides en tant qu'agents actifs pour stabiliser des barrières biologiques |
KR20230156435A (ko) | 2010-07-09 | 2023-11-14 | 바이오버라티브 테라퓨틱스 인크. | 인자 ix 폴리펩티드 및 이들의 사용 방법 |
ES2758352T3 (es) | 2010-11-26 | 2020-05-05 | Molecular Partners Ag | Proteínas de repetición diseñadas que se une a la seroalbúmina |
WO2012170969A2 (fr) | 2011-06-10 | 2012-12-13 | Biogen Idec Ma Inc. | Composés pro-coagulants et leurs procédés d'utilisation |
MY180714A (en) | 2011-07-08 | 2020-12-07 | Bioverativ Therapeutics Inc | Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
EA028914B1 (ru) | 2011-07-25 | 2018-01-31 | Байоджен Хемофилия Инк. | Исследования для мониторинга нарушений свертываемости крови |
NZ626945A (en) * | 2012-01-12 | 2016-10-28 | Biogen Ma Inc | Chimeric factor viii polypeptides and uses thereof |
KR20190094480A (ko) | 2012-02-15 | 2019-08-13 | 바이오버라티브 테라퓨틱스 인크. | 재조합 인자 viii 단백질 |
CN111548418A (zh) | 2012-02-15 | 2020-08-18 | 比奥贝拉蒂治疗公司 | 因子viii组合物及其制备和使用方法 |
CN117462693A (zh) | 2012-02-27 | 2024-01-30 | 阿穆尼克斯运营公司 | Xten缀合组合物和制造其的方法 |
EP3646880A1 (fr) | 2012-05-07 | 2020-05-06 | Allergan, Inc. | Procédé de traitement d'amd chez des patients souffrant d'un état réfractaire à la thérapie anti-vegf |
MX349035B (es) | 2012-05-17 | 2017-07-07 | Extend Biosciences Inc | Portadores para el suministro mejorado de farmaco. |
AU2013283296A1 (en) | 2012-06-28 | 2015-02-05 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to platelet-derived growth factor |
EP3404105A1 (fr) | 2012-07-06 | 2018-11-21 | Bioverativ Therapeutics Inc. | Lignée cellulaire exprimant des polypeptides du facteur viii à chaîne unique et ses utilisations |
PT2882450T (pt) | 2012-07-11 | 2020-02-19 | Bioverativ Therapeutics Inc | Complexo de fator viii com xten e a proteína fator de von willebrand, e utilizações do mesmo |
TWI810729B (zh) | 2012-09-25 | 2023-08-01 | 美商百歐維拉提夫治療公司 | Fix多肽的應用 |
EP2738180A1 (fr) | 2012-11-30 | 2014-06-04 | Molecular Partners AG | Protéines de liaison comportant au moins deux domaines de liaison ciblant HER2 |
AU2014228938B2 (en) | 2013-03-15 | 2019-05-02 | Bioverativ Therapeutics Inc. | Factor IX polypeptide formulations |
WO2015022326A1 (fr) | 2013-08-12 | 2015-02-19 | Xiber Science Gmbh | Peptides en tant qu'agents actifs pour le traitement d'un dysfonctionnement du greffon primaire |
TW202003554A (zh) | 2013-08-14 | 2020-01-16 | 美商百歐維拉提夫治療公司 | 因子viii-xten融合物及其用途 |
US20150126458A1 (en) | 2013-11-05 | 2015-05-07 | Allergan, Inc. | Method of treating conditions of the eye with an anti-vegf darpin |
WO2015070014A1 (fr) | 2013-11-08 | 2015-05-14 | Biogen Idec Ma Inc. | Composé de fusion procoagulant |
SI3091997T1 (sl) | 2014-01-10 | 2022-10-28 | Bioverativ Therapeutics Inc. | Himerni proteini faktorja VIII in njihova uporaba |
CN113248623A (zh) | 2014-06-18 | 2021-08-13 | 阿尔伯特爱因斯坦医学院 | Syntac多肽及其用途 |
WO2016065052A1 (fr) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Conjugués insuline vitamine d |
US9585934B2 (en) | 2014-10-22 | 2017-03-07 | Extend Biosciences, Inc. | Therapeutic vitamin D conjugates |
US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
BR112017020986A2 (pt) | 2015-04-02 | 2018-08-14 | Molecular Partners Ag. | proteínas de ligação recombinantes e seu uso |
JP6983075B2 (ja) | 2015-06-02 | 2021-12-17 | ノヴォ ノルディスク アー/エス | 極性の組換え延長部を有するインスリン |
CA2989400A1 (fr) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Ang1005 pour le traitement de la carcinomatose leptomeningee |
JP6909203B2 (ja) | 2015-08-03 | 2021-07-28 | バイオベラティブ セラピューティクス インコーポレイテッド | 第ix因子融合タンパク質及びそれらの製造方法及び使用方法 |
WO2017040344A2 (fr) | 2015-08-28 | 2017-03-09 | Amunix Operating Inc. | Ensemble de polypeptides chimériques et procédés de préparation et d'utilisation de ceux-ci |
MA43348A (fr) | 2015-10-01 | 2018-08-08 | Novo Nordisk As | Conjugués de protéines |
US11505591B2 (en) | 2016-05-18 | 2022-11-22 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
US11339201B2 (en) | 2016-05-18 | 2022-05-24 | Albert Einstein College Of Medicine | Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof |
CN116970060A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
WO2018185131A2 (fr) | 2017-04-05 | 2018-10-11 | Novo Nordisk A/S | Conjugués insuline-fc à extension oligomère |
KR20200064085A (ko) | 2017-09-07 | 2020-06-05 | 큐 바이오파마, 인크. | 접합 부위를 갖는 t-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법 |
EP3737689A4 (fr) | 2018-01-09 | 2021-12-01 | Cue Biopharma, Inc. | Polypeptides multimères modulateurs de lymphocytes t et leurs procédés d'utilisation |
WO2019201855A1 (fr) * | 2018-04-16 | 2019-10-24 | Swedish Orphan Biovitrum Ab (Publ) | Protéine de fusion lysosomale |
TW202039542A (zh) | 2018-12-19 | 2020-11-01 | 美商庫爾生物製藥有限公司 | 多聚體t細胞調節多肽及其使用方法 |
WO2020181062A1 (fr) | 2019-03-06 | 2020-09-10 | Cue Biopharma, Inc. | Polypeptides multimères modulateurs des lymphocytes t et leurs méthodes d'utilisation |
JP2023538533A (ja) | 2020-08-07 | 2023-09-08 | ブリストル-マイヤーズ スクイブ カンパニー | 線維症の処置のための、ccr2/5拮抗剤と組み合わせたfgf21 |
EP4222176A4 (fr) | 2020-09-30 | 2024-02-28 | Beijing Ql Biopharmaceutical Co Ltd | Conjugués polypeptidiques et leurs procédés d'utilisation |
WO2022115597A1 (fr) | 2020-11-25 | 2022-06-02 | Bristol-Myers Squibb Company | Méthodes de traitement de maladies du foie |
US20240018265A1 (en) | 2020-12-11 | 2024-01-18 | Friedrich Miescher Institute For Biomedical Research | Hdac6 binding proteins and their anti-viral use |
CN115083016A (zh) * | 2022-06-09 | 2022-09-20 | 广州紫为云科技有限公司 | 一种基于单目摄像机的面向小目标手部隔空交互方法与装置 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD257197A1 (de) † | 1987-01-28 | 1988-06-08 | Univ Dresden Tech | Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen |
FR2647677B1 (fr) * | 1989-05-31 | 1991-09-27 | Roussel Uclaf | Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines |
RU2114119C1 (ru) † | 1990-12-13 | 1998-06-27 | Дзе Апджон Компани | Слитой белок и способ выделения слитого белка |
US5833911A (en) † | 1995-05-31 | 1998-11-10 | Johnson & Johnson Medical, Inc. | Method for forming a glove using a folded glove form |
AU5065198A (en) † | 1996-11-15 | 1998-06-10 | Maria Grazia Masucci | Fusion proteins having increased half-lives |
EP1054973A1 (fr) * | 1998-02-11 | 2000-11-29 | Maxygen, Inc. | Immunisation par bibliotheque d'antigenes |
US20050260605A1 (en) * | 1998-02-11 | 2005-11-24 | Maxygen, Inc. | Targeting of genetic vaccine vectors |
US20050287153A1 (en) † | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
US20030049689A1 (en) * | 2000-12-14 | 2003-03-13 | Cynthia Edwards | Multifunctional polypeptides |
US20020169125A1 (en) * | 2001-03-21 | 2002-11-14 | Cell Therapeutics, Inc. | Recombinant production of polyanionic polymers and uses thereof |
JP5735194B2 (ja) * | 2005-01-25 | 2015-06-17 | セル セラピューティクス インコーポレーテッド | 改善された生体内半減期を有する生物学的に活性なタンパク質 |
US8334257B2 (en) † | 2005-12-20 | 2012-12-18 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
SI2402754T2 (sl) | 2006-03-06 | 2023-09-29 | Amunix Operating Inc. | Nestrukturirani rekombinantni polimeri in njihove uporabe |
WO2008049711A1 (fr) † | 2006-10-27 | 2008-05-02 | Novo Nordisk A/S | Insuline à peptide ajouté |
-
2007
- 2007-03-06 SI SI200731588T patent/SI2402754T2/sl unknown
- 2007-03-06 CA CA2644712A patent/CA2644712C/fr active Active
- 2007-03-06 DK DK11172812.7T patent/DK2402754T4/da active
- 2007-03-06 WO PCT/US2007/005857 patent/WO2007103455A2/fr active Application Filing
- 2007-03-06 EP EP07752549A patent/EP1996937A4/fr not_active Withdrawn
- 2007-03-06 AU AU2007223855A patent/AU2007223855B2/en active Active
- 2007-03-06 EP EP07752636.6A patent/EP1996220B2/fr active Active
- 2007-03-06 WO PCT/US2007/005952 patent/WO2007103515A2/fr active Application Filing
- 2007-03-06 EP EP20140189047 patent/EP2863222A1/fr not_active Ceased
- 2007-03-06 AU AU2007223888A patent/AU2007223888A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
BULAJ GRZEGORZ ET AL: "Efficient oxidative folding of conotoxins and the radiation of venomous cone snails.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 100, no. Supplement 2, 25 November 2003 (2003-11-25), pages 14562 - 14568, XP002515375, ISSN: 0027-8424 * |
CHEN X J ET AL: "Site-directed mutations in a highly conserved region of Bacillus thuringiensis delta-endotoxin affect inhibition of short circuit current across Bombyx mori midguts.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1 OCT 1993, vol. 90, no. 19, 1 October 1993 (1993-10-01), pages 9041 - 9045, XP002515378, ISSN: 0027-8424 * |
GOMEZ-DUARTE O G ET AL: "Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 13, no. 16, 1 November 1995 (1995-11-01), pages 1596 - 1602, XP004057422, ISSN: 0264-410X * |
PI C ET AL: "Analysis of expressed sequence tags from the venom ducts of Conus striatus: focusing on the expression profile of conotoxins", BIOCHIMIE, MASSON, PARIS, FR, vol. 88, no. 2, 1 February 2006 (2006-02-01), pages 131 - 140, XP025066514, ISSN: 0300-9084, [retrieved on 20060201] * |
Also Published As
Publication number | Publication date |
---|---|
EP1996220B2 (fr) | 2023-08-16 |
EP1996220B1 (fr) | 2013-05-08 |
EP1996220A4 (fr) | 2009-04-29 |
AU2007223855A1 (en) | 2007-09-13 |
EP2863222A1 (fr) | 2015-04-22 |
CA2644712C (fr) | 2016-09-13 |
CA2644712A1 (fr) | 2007-09-13 |
SI2402754T1 (sl) | 2015-02-27 |
SI2402754T2 (sl) | 2023-09-29 |
AU2007223888A1 (en) | 2007-09-13 |
WO2007103515A3 (fr) | 2008-04-03 |
DK2402754T3 (en) | 2015-01-12 |
WO2007103515A2 (fr) | 2007-09-13 |
EP1996937A2 (fr) | 2008-12-03 |
WO2007103455A3 (fr) | 2007-11-29 |
AU2007223855B2 (en) | 2013-05-16 |
DK2402754T4 (da) | 2023-08-28 |
EP1996220A2 (fr) | 2008-12-03 |
WO2007103455A2 (fr) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1996937A4 (fr) | Materiels génétiques et utilisations correspondantes | |
ZA200810323B (en) | Fkbp-l and uses thereof | |
ZA200810311B (en) | Anti-NKG2A antibodies and uses thereof | |
LT2064327T (lt) | Dbait ir jų panaudojimas | |
ZA200902823B (en) | Oligoribonucleotides and uses thereof | |
IL196397A0 (en) | Prlr-specific antibody and uses thereof | |
AU313874S (en) | Package | |
IL194751A0 (en) | Drugs and uses | |
GB0621160D0 (en) | Compounds and uses thereof | |
HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
IL196861A0 (en) | Antibodies against ccr5 and uses thereof | |
IL195525A0 (en) | Replikin peptides and uses thereof | |
IL193469A0 (en) | Novel lipases and uses thereof | |
EP2124908A4 (fr) | Composés et utilisations de ceux-ci | |
GB0604187D0 (en) | Peptide and uses thereof | |
EP2120563A4 (fr) | Composés et leurs utilisations | |
GB0603717D0 (en) | Electricity-generate and store | |
PL2032708T3 (pl) | Rekombinowane nowirabdowirusy i ich zastosowania | |
EP2099459A4 (fr) | Composés et leurs utilisations | |
IL192800A0 (en) | Fgf2-binding peptides and uses thereof | |
EP2120957A4 (fr) | Composés et leurs utilisations | |
GB0621665D0 (en) | Blogmail and podmail | |
GB2444960B (en) | Combined pseudoscope and hyperscope | |
GB0615557D0 (en) | Compounds and Uses Thereof | |
GB0603397D0 (en) | Handling extended area articles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20081006 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090305 |
|
17Q | First examination report despatched |
Effective date: 20090717 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AMUNIX OPERATING INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110421 |